help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on December 27, 2006
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2006-1201
A more recent version of this article appeared on March 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
92/3/1112    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rutanen, J.
Right arrow Articles by Laakso, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rutanen, J.
Right arrow Articles by Laakso, M.

Submitted on June 5, 2006
Accepted on December 20, 2006

Single nucleotide polymorphisms of the Melanocortin-3 Receptor gene are associated with substrate oxidation and first-phase insulin secretion in offspring of type 2 diabetic subjects

Jarno Rutanen, Jussi Pihlajamäki, Markku Vänttinen, Urpu Salmenniemi, Eija Ruotsalainen, Teemu Kuulasmaa, Sakari Kainulainen, and Markku Laakso*

Department of Medicine, University of Kuopio, Kuopio, Finland; Department of Clinical Radiology, University of Kuopio, Kuopio, Finland

* To whom correspondence should be addressed. E-mail: markku.laakso{at}kuh.fi.

Context: The melanocortin-3 receptor (MC3R) is a part of the melanocortin system that regulates appetite and energy metabolism. The Lys/Thr6 and Ile/Val81 polymorphisms of the MC3R gene have been previously associated with high insulin levels and obesity in children.

Objective: To determine whether single nucleotide polymorphisms (SNPs) of MC3R are associated with glucose, lipid and energy metabolism.

Design, Setting and Participants: We screened the Lys/Thr6 and Ile/Val81 mutations and six non-coding SNPs of MC3R in a cross-sectional study of 216 middle-aged non-diabetic Finnish subjects who were offspring of type 2 diabetic patients.

Main Outcome Measures: Insulin secretion was evaluated by an intravenous glucose tolerance test (IVGTT) and insulin sensitivity and energy metabolism by the hyperinsulinemic euglycemic clamp and indirect calorimetry.

Results: Carriers of the Thr6 and Val81 alleles had significantly lower rates of lipid oxidation (0.85 ± 0.38 vs. 1.00 ± 0.43, mg/kg of lean body mass/min, p=0.022, adjusted for sex, body mass index, age and family relationship) and higher rates of glucose oxidation in the fasting state (11.28 ± 4.64 vs. 9.71 ± 4.53 µmol/kg of LBM/min, p=0.031) than subjects with the Lys/Lys6 and Ile/Ile81 genotypes. They had lower rates of lipid oxidation during the hyperinsulinemic clamp (0.32 ± 0.41 vs. 0.44 ± 0.34 mg/kg of LBM/min, p=0.021) and higher insulin levels in an IVGTT (insulin under the curve during the first 10 minutes, 3220 ± 1765 vs. 2454 ± 1538, pmol/Lxmin, p=0.025) compared to subjects with the common genotypes.

Conclusions: Our results suggest that SNPs of MC3R may regulate substrate oxidation and first-phase insulin secretion.


Key words: Melanocortin-3 receptor • substrate oxidation • insulin secretion • insulin sensitivity







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society